Targeted delivery of a designed sTRAIL mutant results in superior apoptotic activity towards EGFR-positive tumor cellsEdwin Bremer(University Medical Center Groningen), Wijnand Helfrich(University Medical Center Groningen)Journal of Molecular MedicineMay 26, 200810.1007/s00109-008-0348-9Cited by 30SaveCiteExport RISWatch citationsRelated PapersThe epithelial polarity regulator LGALS9/galectin-9 induces fatal frustrated autophagy in KRAS mutant colon carcinoma that depends on elevated basal autophagic flux|Autophagy|2015|54Bispecific antibody CD73xEGFR more selectively inhibits the CD73/adenosine immune checkpoint on cancer cells and concurrently counteracts pro-oncogenic activities of CD73 and EGFR|Journal for ImmunoTherapy of Cancer|2023|13A Novel Bispecific Antibody for EpCAM-Directed Inhibition of the CD73/Adenosine Immune Checkpoint in Ovarian Cancer|Cancers|2023|5